“Zero Food” And The Art Of Deliberate Misrepresentation
Covaxin Phase 3 Trial Data Shows 77.8 Per Cent Efficacy Against Symptomatic COVID, Finds Study Published In Lancet
Serum Institute's Chairman Cyrus Poonawalla Bats For Booster Dose Of Covishield After Six Months
Pfizer COVID-19 Vaccine Produces Less Antibodies Against Delta Variant Of Coronavirus, Finds Study Published In Lancet
Tracing The Origin Question Of Coronavirus And Associated Controversies
Covid-19 Origins And Obfuscations: Those Who Preach About Keeping 'Science At Heart' Must Follow Their Own Advice
Bharat Biotech Covaxin Safe, Generates Immune Response Against COVID-19: Study Published In British Medical Journal Lancet
Sputnik V: Russian Covid-19 Vaccine Developers Respond To Criticism Of Clinical Trial Data In Medical Journal Lancet
Coronavirus: Triple Drug Antiviral Therapy Shows Promise For Treating Covid-19 Patients In Clinical Trial
India Gains Four Spots In Global Human Capital Rankings By Institute for Health Metrics and Evaluation
